IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Influence of Risk Perception and Physician Recommendations on the Adoption of Examinations for Early Detection of Breast, Cervical, Oral and Colon Cancers in Rural Thiruvananthapuram

Original Research, Volume 17 Issue 3 – July to September 2024

Authors

Regi Josea, Renjini Ramachandrana, Paul Augustineb
aDepartment of Community Medicine, Sree Gokulam Medical College & RF;
bDivision of Surgical Oncology, Regional Cancer Center, Thiruvananthapuram.


Abstract

Early cancer detection is crucial in reducing mortality rates, especially in rural areas with limited healthcare access. This cross-sectional study investigates how risk perception and physician recommendations influence the adoption of screening practices for breast, cervical, oral, and colon cancers among 160 women aged 30-65 years in rural Thiruvananthapuram. The findings show that a significant proportion of participants perceived their cancer risk as low, which correlates with lower screening rates. Physician recommendations played a key role in motivating patients to undergo screening, but many did not receive such advice. This highlights the need for enhanced communication between healthcare providers and patients to improve risk awareness and increase cancer screening uptake.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician